Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Thurston County has recorded its first influenza-related death for the 2024-2025 flu season, according to a Friday news ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED ...

NHS England said as of 29 December, there were 87 flu patients at the Royal Devon and Exeter Hospital along with 32 at the ...

Amid rising flu and RSV cases, Laredo health officials urge residents to vaccinate and maintain hygiene, highlighting a spike ...

Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely ...

The United States is experiencing a rise in respiratory illnesses, commonly referred to as a “tripledemic,” involving ...

RSV, and influenza leading to increased hospitalizations. The CDC notes a rise in illness across 40 states and predicts ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...